DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Davies C, Pan H, Godwin J et al.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping
at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS,
a randomised trial.
Lancet 2013;
381: 805-816
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.